153 related articles for article (PubMed ID: 35261697)
1. Vaso reactivity test using inhaled nitric oxide for pulmonary arterial hypertension accompanied by severe interstitial lung disease attributed to systemic sclerosis: A case report.
Yamaguchi T; Izumiya Y; Hayashi O; Hayashi H; Ogawa M; Shibata A; Yamazaki T; Yoshiyama M
J Cardiol Cases; 2022 Mar; 25(3):144-148. PubMed ID: 35261697
[TBL] [Abstract][Full Text] [Related]
2. The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax.
Jacheć W; Tomasik A; Kurzyna M; Pietura R; Torbicki A; Głowacki J; Nowalany-Kozielska E; Wojciechowska C
BMC Pulm Med; 2019 Apr; 19(1):80. PubMed ID: 30991994
[TBL] [Abstract][Full Text] [Related]
3. Is There Value in Repeating Inhaled Nitric Oxide Vasoreactivity Tests in Patients with Pulmonary Arterial Hypertension?
Tooba R; Almoushref A; Tonelli AR
Lung; 2020 Feb; 198(1):87-94. PubMed ID: 31894408
[TBL] [Abstract][Full Text] [Related]
4. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
Antoniou T; Prokakis C; Athanasopoulos G; Thanopoulos A; Rellia P; Zarkalis D; Kogerakis N; Koletsis EN; Bairaktaris A
Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study.
Del Valle KT; Krowka MJ; Schinstock CA; Nath KA; Burger CD; Reddy YN; Frantz RP; Prakash YS; DuBrock HM
Pulm Circ; 2024 Jan; 14(1):e12341. PubMed ID: 38344073
[TBL] [Abstract][Full Text] [Related]
10. Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs.
Yamada T; Yukioka H; Hayashi M; Asada A; Inoue M
Acta Anaesthesiol Scand; 1998 Mar; 42(3):358-68. PubMed ID: 9542566
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
Ishihara S; Kioka H; Ohtani T; Asano Y; Yamaguchi O; Hikoso S; Toda K; Saito Y; Sawa Y; Yamauchi-Takihara K; Sakata Y
Pulm Circ; 2018; 8(3):2045894018770131. PubMed ID: 29575985
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
[TBL] [Abstract][Full Text] [Related]
13. Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.
Olschewski H; Ghofrani HA; Walmrath D; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Intensive Care Med; 1998 Jun; 24(6):631-4. PubMed ID: 9681789
[TBL] [Abstract][Full Text] [Related]
14. Comparison of acute hemodynamic effects of aerosolized iloprost and inhaled nitric oxide in adult congenital heart disease with severe pulmonary arterial hypertension.
Caojin Z; Yigao H; Tao H; Wenhui H; Chunli X; Xinsheng H
Intern Med; 2012; 51(20):2857-62. PubMed ID: 23064558
[TBL] [Abstract][Full Text] [Related]
15. Inhaled iloprost induces long-term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy.
Yasuda K; Adachi S; Nishiyama I; Yoshida M; Nakano Y; Murohara T
Pulm Circ; 2022 Apr; 12(2):e12074. PubMed ID: 35514784
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment for a patient with chronic thromboembolic pulmonary hypertension comorbid with essential thrombocythemia with the JAK2 V617F mutation by balloon pulmonary angioplasty.
Yamaguchi T; Izumiya Y; Hayashi H; Ichikawa Y; Ishikawa H; Shibata A; Yamazaki T; Yoshiyama M
Respir Med Case Rep; 2020; 31():101235. PubMed ID: 33024690
[TBL] [Abstract][Full Text] [Related]
19. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
